Ribbon Acquisition Corp. (RIBB) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated September 10, 2026, details the results of an Extraordinary General Meeting held by Ribbon Acquisition Corp. (the "Company"). The Company, a Cayman Islands entity, is in the process of consummating a business combination with DRC Medicine Ltd. and related entities. The report covers shareholder voting outcomes on eight proposals and the finalization of share redemptions.
Key Financial Metrics and Redemption Activity
The filing does not provide standard operating financial metrics such as revenue, profit, or cash flow, as the Company is a special purpose acquisition company (SPAC) pre-combination. Key financial data relates to the trust account and redemption activity:
- Total Shares Outstanding (Record Date): 5,033,133 ordinary shares.
- Shares Redeemed: 3,429,838 shares (after reversals).
- Aggregate Redemption Amount: Approximately $36,321,984.42.
- Per-Share Redemption Price: Approximately $10.59.
- Remaining Trust Account Balance: Approximately $1,411,594.05.
- Redemption Reversals: 30,633 shares were reversed by shareholders after the meeting.
Material Changes and Voting Results
Shareholders approved all eight proposals submitted at the meeting. The most significant material changes include:
- NTA Proposal: Approved the removal of the $5,000,001 net tangible assets requirement, allowing the business combination to proceed even if redemptions reduce assets below this threshold.
- Domestication: Approved the transfer of the Company from the Cayman Islands to the State of Delaware.
- Business Combination: Approved the agreement with DRC Medicine Ltd. and related merger entities.
- Governance and Capital: Approved new organizational documents, the issuance of shares for the combination and incentive plans, and the election of seven new directors for the post-combination entity (Pubco).
Outlook and Management Commentary
Management intends to file an amendment to the Company's Charter with the Cayman Islands Registrar of Companies promptly. The Company has permitted shareholders to reverse redemption elections, a process that concluded with 30,633 shares remaining subject to redemption. The filing indicates the Company is proceeding toward the consummation of the business combination with DRC Medicine Inc. (Pubco).
Investor Verification Checklist
- Verify the final trust account balance of approximately $1.41 million against the remaining share count post-redemption.
- Confirm the filing of the Certificate of Corporate Domestication with the State of Delaware.
- Review the definitive proxy statement for details on the DRC Medicine Inc. 2026 Incentive Award Plan.
- Monitor the Nasdaq listing status of the new Pubco shares (RIBB) following the domestication and combination.
- Check for any subsequent filings regarding the final closing date of the business combination.